PPD

Precision medicine innovators have access to more biological data and more powerful ways to interrogate it than ever before. Genomics, transcriptomics, proteomics and other high-dimensional technologies can reveal increasingly complex molecular signatures

GMP laboratories have become increasingly important in clinical development as modern therapies grow more complex, regulatory expectations continue to evolve, and development timelines depend on reliable analytical testing and manufacturing. To navigate t

Key takeaways As sponsors scale globally and enter diverse markets, market entry must be reframed as a continuous life cycle Organizations that adopt a lifecycle mindset are better positioned to manage compliance, scale globally and sustain long-term prod

Autosomal dominant polycystic kidney disease (ADPKD) can be easy to underestimate. Cysts may be enlarging and kidney function may be declining while a patient still feels well. For drug developers, this disconnect creates a central challenge: clinical tri

Key takeaways Amid rising clinical trial costs, complexity, and other challenges, organizations are rethinking ways to resource clinical development Highlights from our 2026 FSP Trends Report reveal that FSP partnerships continue to help sponsors navigate

Drug development has always required teams to balance scientific ambition with practical execution. Today, that work is shaped by many intersecting pressures, including scientific innovation, evolving regulatory expectations, patient needs, data demands a

The U.S. Food and Drug Administration's (FDA) May 2026 Optimizing Pregnancy Registries workshop marked a meaningful step in the evolution of pregnancy safety evidence generation. The overarching message was not that pregnancy registries are becoming less

As clinical development becomes increasingly complex, sponsors face growing pressure to accelerate timelines, manage expanding pipelines, access specialized expertise and scale resources efficiently, all while maintaining visibility and control over criti

China's Center for Drug Evaluation (CDE) recently released its Annual Report on the Progress of Clinical Trials for New Drug Registration in China (2025), providing a detailed view of one of the world's most active clinical research environments. Accordin